The fourth episode of Orthocell’s ‘Meet the Board’ video series is now live – featuring Independent Director, Dr. Ravi Thadhani.
As a physician-scientist with 30 years of research experience and a decade as an FDA consultant, Dr. Thadhani brings unique insights into both the clinical and regulatory aspects of Orthocell’s journey. He shares perspectives on why Remplir™ represents a significant advancement in addressing unmet medical needs while reducing complications associated with current nerve repair treatments.
Reflecting on what makes Orthocell such an exciting Company at this time:
“If one asks the question, what should anyone on the outside be looking at? – You’re looking for an outstanding Board, an outstanding scientific team, and importantly an outstanding product that makes a difference in lives. And Orthocell certainly brings all three to the table.”